Literature DB >> 31172908

Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1.

Sangeeta Tiwari1, Rosalyn Casey2, Celia W Goulding3, Suzie Hingley-Wilson2, William R Jacobs1.   

Abstract

Mycobacterium tuberculosis is an ancient master of the art of causing human disease. One important weapon within its fully loaded arsenal is the type VII secretion system. M. tuberculosis has five of them: ESAT-6 secretion systems (ESX) 1 to 5. ESX-1 has long been recognized as a major cause of attenuation of the FDA-licensed vaccine Mycobacterium bovis BCG, but its importance in disease progression and transmission has recently been elucidated in more detail. This review summarizes the recent advances in (i) the understanding of the ESX-1 structure and components, (ii) our knowledge of ESX-1's role in hijacking macrophage function to set a path for infection and dissemination, and (iii) the development of interventions that utilize ESX-1 for diagnosis, drug interventions, host-directed therapies, and vaccines.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31172908      PMCID: PMC6698389          DOI: 10.1128/microbiolspec.BAI-0024-2019

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  113 in total

1.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 2.  The Enigmatic Esx Proteins: Looking Beyond Mycobacteria.

Authors:  Meera Unnikrishnan; Chrystala Constantinidou; Tracy Palmer; Mark J Pallen
Journal:  Trends Microbiol       Date:  2016-11-25       Impact factor: 17.079

3.  EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion.

Authors:  Ye Lou; Jan Rybniker; Claudia Sala; Stewart T Cole
Journal:  Mol Microbiol       Date:  2016-11-25       Impact factor: 3.501

4.  In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis.

Authors:  R A McAdam; T R Weisbrod; J Martin; J D Scuderi; A M Brown; J D Cirillo; B R Bloom; W R Jacobs
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

5.  L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis.

Authors:  A P Gobert; S Daulouede; M Lepoivre; J L Boucher; B Bouteille; A Buguet; R Cespuglio; B Veyret; P Vincendeau
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis.

Authors:  Michael Berney; Linda Berney-Meyer; Ka-Wing Wong; Bing Chen; Mei Chen; John Kim; Jingxin Wang; David Harris; Julian Parkhill; John Chan; Feng Wang; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-28       Impact factor: 11.205

7.  Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Authors:  Wenliang Zhang; Youngjoo Choi; Lia M Haynes; Jennifer L Harcourt; Larry J Anderson; Les P Jones; Ralph A Tripp
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

8.  Infection by tubercular mycobacteria is spread by nonlytic ejection from their amoeba hosts.

Authors:  Monica Hagedorn; Kyle H Rohde; David G Russell; Thierry Soldati
Journal:  Science       Date:  2009-03-27       Impact factor: 47.728

9.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

10.  An attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathology.

Authors:  Helena Strand Clemmensen; Niels Peter Hell Knudsen; Erik Michael Rasmussen; Jessica Winkler; Ida Rosenkrands; Ahmad Ahmad; Troels Lillebaek; David R Sherman; Peter Lawætz Andersen; Claus Aagaard
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

View more
  12 in total

Review 1.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

Review 2.  Bag it, tag it: ubiquitin ligases and host resistance to Mycobacterium tuberculosis.

Authors:  Priscila C Campos; Danielle T Cunha; Luiz P Souza-Costa; Michael U Shiloh; Luis H Franco
Journal:  Trends Microbiol       Date:  2022-04-29       Impact factor: 18.230

Review 3.  Macrophage: A Cell With Many Faces and Functions in Tuberculosis.

Authors:  Faraz Ahmad; Anshu Rani; Anwar Alam; Sheeba Zarin; Saurabh Pandey; Hina Singh; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis.

Authors:  Sangeeta Tiwari; Taru S Dutt; Bing Chen; Mei Chen; John Kim; Annie Zhi Dai; Regy Lukose; Crystal Shanley; Amy Fox; Burton R Karger; Steven A Porcelli; John Chan; Brendan K Podell; Andres Obregon-Henao; Ian M Orme; William R Jacobs; Marcela Henao-Tamayo
Journal:  Vaccine       Date:  2020-09-23       Impact factor: 3.641

Review 5.  Editorial: Cellular and Molecular Mechanisms of Mycobacterium tuberculosis Virulence.

Authors:  Jianjun Sun; Patricia A Champion; Fabiana Bigi
Journal:  Front Cell Infect Microbiol       Date:  2019-10-09       Impact factor: 5.293

6.  Comparative Genomic and Transcriptomic Analyses of Mycobacterium kansasii Subtypes Provide New Insights Into Their Pathogenicity and Taxonomy.

Authors:  Qingtian Guan; Roy Ummels; Fathia Ben-Rached; Yara Alzahid; Mohammad S Amini; Sabir A Adroub; Jakko van Ingen; Wilbert Bitter; Abdallah M Abdallah; Arnab Pain
Journal:  Front Cell Infect Microbiol       Date:  2020-03-24       Impact factor: 5.293

7.  Vaccines Against Tuberculosis: Problems and Prospects (Review).

Authors:  N I Nadolinskaia; D S Karpov; A V Goncharenko
Journal:  Appl Biochem Microbiol       Date:  2020-09-22       Impact factor: 1.065

8.  A type VII secretion system of Streptococcus gallolyticus subsp. gallolyticus contributes to gut colonization and the development of colon tumors.

Authors:  John Culver Taylor; Xinsheng Gao; Juan Xu; Michael Holder; Joseph Petrosino; Ritesh Kumar; Wen Liu; Magnus Höök; Chris Mackenzie; Andrew Hillhouse; Wesley Brashear; Maria Patricia Nunez; Yi Xu
Journal:  PLoS Pathog       Date:  2021-01-06       Impact factor: 6.823

Review 9.  Mycobacterial virulence: impact on immunogenicity and vaccine research.

Authors:  Vera M Kroesen; Jan Madacki; Wafa Frigui; Fadel Sayes; Roland Brosch
Journal:  F1000Res       Date:  2019-11-28

Review 10.  Lipid droplets and the transcriptome of Mycobacterium tuberculosis from direct sputa: a literature review.

Authors:  Daniel Mekonnen; Awoke Derbie; Adane Mihret; Solomon Abebe Yimer; Tone Tønjum; Baye Gelaw; Endalkachew Nibret; Abaineh Munshae; Simon J Waddell; Abraham Aseffa
Journal:  Lipids Health Dis       Date:  2021-10-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.